Assessment of safety & Efficacy of cosmetic product

Recruitment & Eligibility

Status: ot Yet Recruiting

Sex: Not specified

Target Recruitment: 0

Inclusion Criteria

1)Indian / Asian female subjects.

2) Healthy subjects (no infectious and evolutive pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory checkup).

3)Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scarâ?¦.).

4)For group A:Having darkspots (acne Post Inflammatory Hyperpigmentation) on face, Having uneven skin tone.

5)For group B:Having mixed oily or oily skin type , with visible pore.Having open, closed comedons.

Exclusion Criteria

1)Being pregnant or breastfeeding or having stopped to breastfeed in the past three months.

2)Having refused to give her assent by signing the consent form.

3)Taking part in another study liable to interfere with this study.

4)Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area

5)Being insulin-dependent diabetic or non-insulin-dependent diabetic with a recent therapy (less than 6 months).

6)Having a progressive asthma (either under treatment or last fit in the last 2 years)

7)Being epileptic.

8)Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months).

9)Having cutaneous hypersensitivity.

10)Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products or food products or to latex.

11)Having known allergy to any of the Ingredient of the Test Product.

12)Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol).

13)Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months.

14)Having changed her cosmetic habits in the 14 days preceding the start of the study on the studied anatomic unit.

15)Having applied a cosmetic product (included make-up) on the studied areas the first day of the study (only face cleaned with water is accepted).

16)Refusing to follow the restrictions below during the study:-Do not take part in any family planning activities leading to pregnancy and breastfeeding-Do not take part in another study liable to interfere with this study -Do not take medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol)-Do not change her cosmetic habits apart from the particular conditions mentioned in the protocol, on the studied anatomic unit -During the study: Do not use other cosmetic products than the tested products to the studied areas (only usual cleanser/soap is accepted),-The day of the measurements: No test product must be used (only face cleaned with water is accepted).

17)Having started, changed or interrupted one hormonal treatment (hormonal contraception, Hormone Replacement Therapy) during the past 3 months.

18)Having started, changed or stopped her tobacco consumption (for smokers consuming more than 10 cigarettes per day) in the previous 6 months.

19)Having consumed caffeine-based products (coffee, cola, tea, â?¦), alcohol, highly spiced food and/or not smoke in the two hours preceding the measurements.

20)Having taken a medicinal treatment which could lead to hyper pigmentation (phenytoÃ¯n, amiodarone, metals, minocyclineâ?¦) in the previous 6 months.

21)Taking oral supplements with major or minor effect on whitening of skin (e.g. vitamin C, beta-caroteneâ?¦).

22)Having had beauty treatment (e.g. skin cleansing, exfoliation, scrub, mask â?¦) or having applied self-tanning products in the week preceding the start of the study.

23)Having applied products with an anti-wrinkle action particularly firming products (Retinoic acid, retinol, retinaldehyde, Alpha Hydroxy Acid) in